HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2024. The put-call ratio across all filers is 1.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $373,947 | +8.6% | 11,136 | +4.5% | 0.00% | 0.0% |
| Q4 2023 | $344,253 | -3.7% | 10,658 | -2.3% | 0.00% | 0.0% |
| Q3 2023 | $357,357 | -19.6% | 10,905 | -13.6% | 0.00% | -20.0% |
| Q2 2023 | $444,203 | -3.9% | 12,623 | -10.9% | 0.01% | 0.0% |
| Q1 2023 | $462,357 | – | 14,161 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $545,757,000 | 83.25% |
| Nan Fung Group Holdings Ltd | 768,708 | $37,398,000 | 17.74% |
| venBio Partners LLC | 1,544,484 | $75,139,000 | 16.66% |
| Vivo Capital, LLC | 4,570,148 | $222,338,000 | 15.31% |
| HealthInvest Partners AB | 120,000 | $5,838,000 | 9.30% |
| Aisling Capital Management LP | 342,815 | $16,678,000 | 9.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 205,474 | $20,533,000 | 4.63% |
| ASHFORD CAPITAL MANAGEMENT INC | 659,873 | $32,103,000 | 3.46% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $14,595,000 | 2.92% |
| Newlight Partners LP | 651,372 | $31,689,000 | 2.15% |